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CASE REPORTS
Familial Glomerulonephritis Characterized by Massive Deposits 
of Fibronectin
Karel J.M. Assmann, MD, Robert A.P. Koene, MD, and Jack F.M. Wetzels, MD
•  In recent years more than 150 cases of glomerulonephritis characterized by deposits of irregularly arranged 
fibrils have been documented. In the majority of these cases immunoglobulins and complement are the prime 
constituents of these deposits. We recently made a diagnosis of fibrillary glomerulonephritis without immunoglobu­
lin deposition in two members of a family, a father and a son. In the father, proteinuria was first discovered 18 
years ago. In 1985 he was referred to our outpatient clinic because of hypertension and increasing proteinuria. 
From that time onward he was regularly seen for blood pressure control, Nephrotlc-range proteinuria persisted, 
without hardly any evidence of deterioration of renal function. Renal biopsies were performed in 1985 and 1993. 
His son underwent a renal biopsy in 1993 because of moderate proteinuria. The biopsies of both patients disclosed 
a distinct form of fibrillary glomerulonephritis that was characterized by massive deposits of a homogeneous, 
eosinophilic material in the mesangial and subendothelial areas. Staining for amyloid was negative. Immunofluo­
rescence revealed that the biopsy specimens only stained faintly for immunoglobulins, complement factors C lq  
and C3, the extracellular matrix proteins, collagen IV, and laminln, However, they strongly stained for fibronectin. 
Using monoclonal antibodies specific for cell-derived fibronectin (lST-9) and plasma- and cell-derived fibronectin 
(IST-4), in the biopsy of the son we demonstrated that the fibronectin deposited in the glomeruli was mainly 
derived from the plasma, and to a lesser extent from resident glomerular cells. In addition, a moderate staining 
for amyloid P and vitronectin also was present. No or minor enhanced staining for collagen I, HI, or V, heparan 
sulfate proteoglycan or its glycosaminoglycan side chains, tenascin, or thrombospondin could be observed. By 
electron microscopy the deposits in the mesangîum and the subendothelial spaces appeared focally to be com­
posed of irregularly arranged fibrils or microtubules 10 to 12 nm in diameter. Fibrillary glomerulonephritis with 
massive deposits of fibronectin represents a rare form of familial glomerulonephritis. In our patients the glomerulo­
nephritis has an indolent course with hardly any deterioration of renal function.
© 1995 by the National Kidney Foundation, Inc.
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HE FINDING of fibrillary deposits in renal 
glomeruli is predominantly associated with 
amyloidosis. In 1977, Rosenmann and Eliakim 
described a patient who suffered from a nephrotic 
syndrome associated with renal deposits of amy­
loid-like material, which did not stain with the 
specific amyloid stains Congo reel or thioflavin- 
T .1 Since then more than 150 cases of this 
“ Congo red-negative amyloid-like glomerulopa­
thy” have been described .2' 12 Based on the ultra- 
structural appearance of the deposited material, 
this form of glomerulonephritis has been divided 
into two distinct entities, fibrillary glomerulone­
phritis and immunotactoid nephropathy .‘M2 Char­
acteristically, these forms o f  glomerulonephritis 
demonstrate massive deposits of immunoglobu­
lins and complement, suggesting an immune 
complex mechanism of the induction of glomeru­
lonephritis, More recently, cases have been docu­
mented of patients with fibrillary glomerulone­
phritis, in which the renal deposits did not 
contain immunoglobulins or complement.M“17 
We present two patients from one family with a 
form of fibrillary glomerulonephritis, character­
ized by massive deposition o f  fibronectin. Fur­
ther studies in one patient revealed that amyloid 
P and vitronectin coprecipitated with the fibro­
nectin.
CASE REPORTS
Case No, /
Putieni no. I is a 48-year-okl man wiih chronic obstructive 
pulmonary disease. In 1976 low-grade proteinuria and hyper­
tension were discovered at routine physical examination. He 
was initially treated with metoprolol and chlorthalidone, and 
subsequently with verapamil, triamterene, and epiti/.ide. In 
1984 he received w venous bypass because of a right subcla­
vian artery stenosis. In 1985 he was referred to our outpatient 
clinic because of increasing proteinuria, Physical examination 
at that time revealed the blood pressure to he 150/100 mm Mg, 
hut was otherwise unremarkable. Laboratory investigation 
revealed the following values: serum creatinine 79 //mol/L,
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albumin 27 g/L, and hemoglobin 9.1 mmol/L. Urinary protein 
excretion averaged 6.4 g/24 hr, selectivity index (calculated 
as renal clearance of immunoglobulin G [IgG] divided by the 
renal clearance of albumin) was 0,17 and 0.22 on separate 
occasions. Antinuclear antibodies were negative, and the 
complement profile was normal. No cryoglobulins or para­
proteins were demonstrated. Calculated creatinine clearance 
was 100 mL/min. A renal biopsy was performed. The ne­
phrotic syndrome persisted over the next 8 years. Treatment 
consisted of verapamil, furosemide, enalapril, and bronchodi-
1 a tors. Simvastatin was added recently because o f  persistent 
hypercholesterolemia (9 to 16 mmol/L). Recent laboratory 
values demonstrated a slight decrease in renal function with 
serum creatinine averaging 100 /imoI/L, albumin 26 g/L, 
proteinuria 6 to 8 g/24 hr, and creatinine clearance 85 mL/ 
min. The patient’s serum fibronectin level was measured by 
immunoelectrophoresis and amounted to 50% of the value 
in normal control serum. A second renal biopsy was per­
formed.
Case No. 2
Patient no. 2 is the 2 1-year-old son of patient no. 1. Protein­
uria was discovered at a military screening at the age of 
18 years. He visited our outpatient clinic in 1993, Physical 
examination was unremarkable. Laboratory investigation re­
vealed the following values: serum creatinine 76 /iinol/L, 
serum albumin 45 g/L, and urinary protein excretion 2.8 gJ 
24 hr. Antinuclear antibodies were negative, the complement 
was normal, and cryoglobulins and paraproteins were absent, 
A renal biopsy was performed.
Additional Family History
Both parents of patient no. 1 have died (from pulmonary 
carcinoma and myocardial infarction, respectively), and in­
formation on urinary protein is lacking. Patient no. 1 has five 
brothers and two sisters, none of whom has ever demonstrated 
proteinuria. Patient no, I lias two sons, in one o f  whom 
(patient no. 2) proteinuria was detected.
MATERIALS AND METHODS
Light Microscopy
A portion of the kidney biopsy specimen was fixed in 
Bouin’s solution, dehydrated, and embedded in paraplast 
(Amstelstad, Amsterdam, The Netherlands). Two-micrometer 
sections were stained with heniatoxylin-eosin, periodic acid- 
Schiff, silver me the mi mine, and Congo red.
Immunofluorescence
Kidney fragments were snap-frozen in liquid nitrogen, and 
2-'fxm cryostat sections were incubated with the antibodies 
listed in Table 1. Fluorescein-labeled antisera directed to hu­
man IgG, IgM, IgA, kappa and lambda light chains, C lq , C3, 
and fibrinogen were used in the direct immunofluorescence 
technique. The other polyclonal or monoclonal antibodies 
were visualized by indirect immunofluorescence or immu no­
peroxidase techniques. For the polyclonal rabbit anti sera we 
used fluorescein- or peroxidase-labeled swine anti-rabbit Ig, 
diluted 1:80 (DAKO, Copenhagen, Denmark). After binding 
of the peroxidase-labeled antibodies, the sections were incu­
bated with 0.05% di ami nobenzidine medium containing 0.6%
Table 1. Antibodies Used for Immunohistology
Specificity Dilution Manufacturer
IgG* 1:400 Central Laboratory of 
the Blood
Transfusion Service
(Amsterdam, The 
Netherlands)
IgM* 1:200 DAKO (Copenhagen, 
Denmark)
IgA* 1:400 DAKO
Kappa* 1:60 DAKO
Lambda* 1:64 DAKO
G1q* 1:160 DAKO
C3* 1:400 DAKO
Fibrin* 1:800 DAKO
Collagen
It 1:20 Monosan Sanblo 
(Uden, The 
Netherlands)
III* 1:10 Monosan, Sanblo
ivt 1:800 Cappel, Organon 
Teknlka NV 
(Turnhout, Belgium)
Vf 1:20 Monosan, Sanblo
Laminint 1:400 Eurodlagnostlcs (Oss, 
The Netherlands)
Fibronectin
Clone I* 1:60 Tellos (San Diego, CA)
Clone II* 1:200 Telios
Clone tl It 1:400 Tellos
IST-4* Undiluted Gift, Dr Zardi (Genova, 
Italy)
IST-9* Undiluted Gift, Dr. Zardi
Heparan sulfate 1:200 Gift, Dr van den Born
proteoglycan (Nijmegen, The 
Netherlands)
Heparan sulfate 1:800 Gift, Dr van den Born
glycosaminoglycan
Amyloid P* 1:160 DAKO
Tenascln* 1:500 Tellos
Trombospondin* 1:100 Telios
Vitronectin* 1:320 Tellos
* Polyclonal, fluorescein-labeled antibodies used In direct im­
munofluorescence.
t  Polyclonal, unlabeled rabbit antibodies used In Indirect immu­
nofluorescence or with the Immunoperoxidase technique. Binding 
of the antibodies was visualized by a fluorescein- or peroxidase- 
labeled swine anti-rabbit antibody, diluted 1:80 (DAKO).
* Mouse monoclonal antibodies, the binding of which was de­
tected by a fluorescein- or peroxidase-labeled sheep anti-mouse 
Ig antibody (Cappel, Turnhout, Belgium) in Indirect Immunofluo­
rescence or with the Immunoperoxidase technique.
Tris for 10 minutes, followed by diaminobenzidine with the 
addition of 7 fiL  of 30% H20 2 for 7 minutes. Binding of the 
mouse monoclonal antibodies was detected with a fluores­
cein-labeled sheep anti-mouse Ig antibody, diluted 1:500 
(Cappel). Two monoclonal anti fibronectin antibodies were a 
kind gift of Dr Luciano Zardi (Genova, Italy): clone IST-4, 
which detects both plasma- and cell-derived fibronectin, and 
clone IST-9, which is specific for the EDA repeats (extra 
domain A o f  fibronectin) and only detects cel I-derived fibr-
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nectin.18,19 The monoclonal antibodies specific for human he­
paran sulfate proteoglycan (JM 72) and the heparan sulfate 
glycosaminoglycan chains (JM 403) were kindly provided by 
Dr J. van den Born (Nijmegen, The Netherlands).20'21 Frozen 
sections from the normal parts of a kidney removed for the 
presence of an adenocarcinoma served as controls. In addi­
tion, in the indirect labeling technique, incubation of the sec­
ond labeled antibody alone was used as a control. The staining 
intensity was recorded semiquuntitatively on a scale from 0 
to 4*K
Electron Microscopy
For electron microscopy a small piece of Lhe biopsy speci­
men was fixed in 2.5% ghitaraldehyde dissolved in 0.1 mo)/ 
L sodium cacodylate buffer, pH 7.2, for 4 horn’s at 4°C and 
washed in the same buffer. The tissue frag men ts were post- 
lixed in phosphate-buffered 2% 0 s 0 4  for 2 hours, dehy­
drated, and embedded in Epon 812. Ulinithin section were 
cut in an ultra to me (LKB Produeteer, Bromma, Sweden) and 
stained with 5% uranyl acetate for 45 minutes and with lead 
citrate for 2 minutes at room temperature. The sections were 
examined using a JEOL 1200 EX2 electron microscope 
(JEOL, Tokyo, Japan). The measurement of the diameter of 
the fibrils was done on photographic prints that automatically 
depicted a calibrated bar with nanometer scale.
RESULTS
Morphologic Findings
Case no. 1. Specimens from the first and sec­
ond biopsies of the father performed in 1985 and 
1993 demonstrated identical lesions by light mi­
croscopy. All glomeruli were enlarged due to ail 
excessive accumulation of a homogeneous and 
eosinophilic, periodic acid-Schiff-positive mate­
rial in the mesangial areas and sometimes to a 
lesser extent along the subendothelial side of the 
glomerular basement membrane (Fig 1). M esan­
gial cells were slightly increased in number and 
dispersed in this material. Using silver methena- 
mine staining, remnants of the mesangial matrix 
occasionally were seen as black fibers in the eo­
sinophilic material. The capillary loops were dis­
placed to the periphery of the glomeruli, but did 
not demonstrate microaneurysmatie changes (Fig 
IB). No influx of inflammatory cells into the 
glomeruli was observed. The glom erular base­
ment membrane and the visceral epithelial and 
endothelial cells were normal. Fibrosis was pres­
ent in the interstitium focally that was accompa­
nied by a few mononuclear cells and tubular atro­
phy. The second biopsy, performed 8 years after 
the first one, showed hardly any progression o f  
the glomerular lesions, although the interstitial 
fibrosis had moderately increased. In specimens 
from both biopsies, Congo red stained sections
viewed under polarized light did not reveal am y­
loid deposits.
Our initial immunofluorescence study of speci­
mens from the first biopsy was restricted to the 
detection of immunoglobulins, complement fac­
tors, and fibrinogen because we were unaware of 
the precise nature of the glomerulopathy at that 
time, We later extended our immunofluorescence 
studies (Table 2) based on the report o f  Maz- 
zucco et al.M There was no staining for IgG or 
C3. Fine or coarse granular deposits o f  IgM, C lq , 
or kappa or lambda light chains were only found 
at the periphery of the material deposited in the 
glomeruli (Fig 2A), Only scant deposits of IgA 
were observed. Polyclonal antisera to collagen 
IV or laminin failed to stain the mesangial depos­
its, with the exception of the putative remnants of 
the mesangial matrix (Fig 2B and C). However, a 
strong diffuse homogeneous staining of the de­
posits was demonstrated with several monoclonal 
antibodies specific for fibronectin (Fig 2D). No 
deposits outside the glomeruli were present. In 
specimens from the second biopsy frozen for 
immunohistologic studies, no glomeruli were 
present.
Electron microscopy o f  specimens from the 
first biopsy showed massive deposits of a fine 
granular appearance that occupied the mesangial 
areas specifically and, to a lesser extent, the sub­
endothelial space (Fig 3A). The glomerular base­
ment membrane had a normal appearance and 
width. The foot processes of the glomerular vis­
ceral epithelial cells showed hardly any sign of 
fusion (Fig 3A), At higher magnification the de­
posits still seemed to be composed of a struc­
tureless fine granular material (Fig 3B) alternat­
ing with areas in which more regularly arranged 
fibrils were seen with a diameter of 10 to 12 nm 
(Fig 3C). Some fibrils had more of an appearance 
of tubular structures. The specimen from (he sec­
ond biopsy used for the electron microscopy did 
not contain glomeruli.
Case no. 2. The biopsy of the son showed 
glomerular lesions similar to those seen in the 
biopsy of his father: massive homogeneous, eo­
sinophilic, periodic acid-Schiff-positive depos­
its mainly located in the mesangial areas (Fig 4). 
Congo red staining was negative. Immunofluo­
rescence showed strong diffuse staining for fi­
bronectin (Fig 5A and B). This fibronectin was 
mainly stained by the IST-4 monoclonal antibod­
ies specific for cell- and plasma-derived iibro-
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Table 2. Immunohistologic Findings of the Kidney
Biopsy Specimens
Antisera Patient No. 1* Patient No. 2
IgG —.
IgM + ±
IgA •h
Kappa *+■
Lambda
C1 q + +
C3
Fibrin —
Collagen
i
III + +
IV 4- -bIM<V
V — —
Laminin — —
Fibronectin
Clone I + + + + + + +
Clone II H— I—I—t” i 1 lit
Clone ill • j "  wjw w |* ■ |  M
IST-4 ND Hb "J" -f-
I ST-9 ND + +
Heparan sulfate
proteoglycan ND —
Heparan sulfate
glycosaminoglycan ND —
Amyloid P ND + +
Tenascin ND
Trombospondin ND
Vitronectin ND + +
Abbreviation: ND, not done.
NOTE. Intensity of the staining was semiquantltativeiy 
recorded from 0 to 4+. Monoclonal antibodies: fibronectin 
clone I binds to the COOH-terminai portion of fibronectin, 
clone II binds to the cell attachment site, clone 111 reacts
near the gelatin-binding domain, IST-4 is specific for all 
different isoforms of fibronectin (plasma and cell derived), 
and IST-9 is specific for the EDA repeats of fibronectin 
(cell-derived). Monoclonal antibodies IST-4 and IST-9 
were a kind gift from Dr L. Zardi (Genova, Itaiy), and mono­
clonal antibodies to heparan sulfate proteoglycan (JM 12) 
and heparan sulfate glycosaminoglycan (JM 403) ware 
kindly provided by Dr. van den Born (Nijmegen, The Neth­
erlands).
* Specimen from the biopsy performed in 1993. No ma­
terial was available for immunofluorescence.
nectin (Fig 5A), and to a much lesser degree by 
IST-9 monoclonal antibodies specific for only 
cell-derived fibronectin (EDA repeat) (Fig 5B), 
suggesting that the fibronectin that has accumu­
lated in the glomeruli is mainly derived from 
the plasma. Direct immunofluorescence did not 
reveal IgG. Fine to coarse granular deposits with 
moderate intensities o f  IgM, C lq ,  C3, IgA, and 
kappa and lambda light chains were found only 
in the periphery of the deposits (Fig 5C).
In addition to the diffuse staining for fibronec­
tin, moderate staining also was seen for amyloid 
P and vitronectin (Fig 5D and E). Staining of the 
deposits for collagen I, III, IV, and V, laminin, 
heparan sulfate proteoglycan and its heparan sul­
fate glycosaminoglycan side chains, tenascin, 
and thrombospondin were negative or negligible 
(Table 2; Fig 5F). Ultrastructurally, the material 
was more compact than in the biopsy of the fa­
ther, but still showed a fine granular aspect (Fig 
6A). Dispersed within this material were fibrils 
or even tubule-like structures that were clearly 
visible and had a diameter of 10 to L2 nm (Fig 
6B and C). The glomerular basement membrane 
was normal, and the epithelial foot processes 
were preserved.
DISCUSSION
In recent years several cases o f  glomerulone­
phritis, characterized by deposits of irregularly 
arranged fibrils or microtubules in the mesangial 
areas, have been documented .1' 12 In the majority 
of these cases o f  * 'fibrillary glomerulonephritis,' ’ 
immunoglobulins and complement are the prime 
constituents of these deposits, suggesting an im­
mune mechanism as a cause of these diseases.
Our patients present a distinct form of fibril­
lary glomerulonephritis in which the deposits do 
not contain immunoglobulins or complement, but
fibronectin .22 Ultra-stsi 0
structural studies also separate this form of glo­
merulonephritis from the immunoglobulin-con­
taining fibrillary glomerulonephritis; the size of 
the fibrils in the latter varies from 20 to 50 nm 
in diameter, whereas in our patients the fibrils 
measured 10 to 12 nm in diameter.
< ........... ........ ....................................................... ..................  ~  ^  I ~ ' 1  I ----------- III . » « I  Ml .»  ....... . —  M -
Fig 2, (A) Immunofluorescence of a specimen from the first biopsy performed in patient no, 1* Scanty deposits 
of C1q can be seen in the periphery of the capillary loops. Most of the eosinophilic material did not stain for 
immunoglobulins or complement. (Magnification X320.) (B, C, and D) Immunoperoxidase staining for laminin (B), 
collagen IV (C), and fibronectin (D). A monoclonal antibody specific for fibronectin strongly stained the glomerular 
deposits, while no important increase for collagen IV or laminin was observed. (Magnification X300.)
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Fig 3. Electron microscopy of a specimen from the first biopsy performed in patient no. 1. (A) Extensive fine 
granular deposits in the mesangium and in the subendothelial spaces can be seen. No fusion of the epithelial foot 
processes was present. (Magnification x15,400.) (B) Higher magnification shows granular material with a vague 
fibrillary substructure. (Magnification x120,000.) (C) Fibrils with a diameter of 10 to 12 nm were present focally.
(Magnification x 120,000.)
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Fig 4. Light microscopy 
of specimen from the biopsy 
performed in patient no. 2 
shows an enlarged glomeru­
lus with massive accumu­
lation of an eosinophilic 
material in the mesangium. 
(Magnification X640.)
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Fig 5. Immunofluorescence of a specimen from the biopsy performed in patient no. 2, (A) Strong staining for 
fibronectin with clone IST-4 (plasma- and cell-derived fibronectin). (Magnification x160.) (B) Moderate staining 
with clone IST-9 (cell-derived fibronectin). (Magnification X115.) (C) Faint staining for IgM at the periphery of 
the glomerulus. (Magnification x115.) (D and E) Moderate staining for amyloid P and vitronectin, respectively. 
(Magnification x115.) (F) Faint staining for tenascin. (Magnification X115.)
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Fig 6. Electron microscopy of a biopsy specimen from patient no. 2. (A) Extensive subendothelial and mesangial 
deposits are seen. Epithelial foot processes are not fused. (Magnification x7,200.) (B and C) At higher magnification 
fibrils or tubule-like structures with a diameter of 10 to 12 nm are seen longitudinally (B) or in cross-section (C). 
(Magnifications: B, x 120,000; C, X176,000.)
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Our patient data closely resemble the findings 
reported by Mazzucco et al.u These investigators 
also described a familial glomerulonephritis 
(mother and daughter affected) characterized by 
massive deposits of fibrillary material that was 
shown on immunofluorescence to be mainly 
composed of fibronectin. This fibronectin was 
strongly stained with the monoclonal antibody 
IST-4, which detects all isoforms of fibronectin, 
whether derived from plasma or the glomerular 
cells; in contrast, no staining was observed with 
IST-9, a monoclonal antibody that specifically 
recognizes cell-derived fibronectin.
W e have further extended the observations of 
Mazzucco et al. The deposits in our patients 
showed no or only weak reactivity with immuno­
globulins, complement, collagen I, III, IV, and 
V, laminin, heparan sulfate proteoglycans or its 
glycosaminoglycan side chains, tenascin, or 
thrombospondin. Strong staining was observed 
with IST-4, whereas moderate staining was ob­
served with IST-9, suggesting that some of the 
deposited fibronectin might be cell derived. In 
addition to fibronectin we demonstrated the pres­
ence of amyloid P and vitronectin in the deposits.
Fibrillary glomerulonephritis appears to be a 
heterogeneous group of glomerulopathies char­
acterized by deposits of variable composition .'l)"12 
Cases of a familial lobular glomerulopathy have 
been described in earlier reports, and may repre­
sent examples of the fibrillary glomerulonephritis 
in our patients.15' 17 However, in these studies the 
exact nature of the deposited material was not 
defined. Furthermore, additional patients have 
been described in which the material did not stain 
with fibronectin, suggesting that other matrix 
components may be involved, Based on the avail­
able data it is impossible to draw conclusions on 
the natural history of these forms of glomerulo­
nephritis. However, both in our patients and in 
the patients described by Mazzucco et al,14 
disease follows a rather indolent course, with 
longstanding proteinuria but almost no progres­
sion to renal insufficiency,
The mesangial matrix of the normal human 
glomerulus is composed immunohistologieally 
o f  numerous components, including collagen 
types IV and V, laminin, entactin, fibronectin, 
amyloid P, heparan sulfate and chonclroitin/der- 
matan proteoglycans such as decorin and bygly- 
can, tenascin, thrombospondin, and vitronec­
tin .23"32 In addition, activated mesangial cells
secrete the interstitial types collagen I and III, 
which are not produced in vivo under normal 
conditions.23,24 In most renal diseases character­
ized by an increased production of mesangial ma­
trix, all the above-mentioned extracellular com­
ponents participate equally in the composition of 
mesangial sclerotic lesions.24'27,29'31"33 An intri­
guing feature of the glomerulonephritis in our 
patients is the restricted accumulation in the mes­
angial and subendothelial areas of the glomerulus 
of only a few components of the mesangial extra­
cellular matrix, ie, fibronectin and, to lesser de­
gree, amyloid P and vitronectin. Such a restricted 
accumulation also has been reported for collagen 
III .34-15
Fibronectin is a dimeric glycoprotein con­
sisting o f  two similar 250-kd subunits held to­
gether at the carboxyl-termini by 
bonds .36,37 Several domains function as binding 
sites for numerous molecules, such as heparin, 
collagen, and cell surface proteins (integrins), 
that are involved in m atrix -m atrix  and ce l l-m a -  
trix interactions. Fibronectin can exist in two 
forms, a soluble form found in blood plasma and 
body fluids and an insoluble form consisting of 
disulfide-bound multiniers of fibronectin in base­
ment membranes and extracellular matrices.37 It 
has been found that plasma-derived fibronectin 
produced and secreted by hepatocellular cells 
lacks the EDA domain (IST-9 monoclonal anti­
body) that has not been spliced off from fibro­
nectin RN A produced by other cells, such as glo­
merular mesangial cells .18,19
Based on our findings in both patients, it is 
tempting to speculate about the cause of the accu­
mulation of the fibronectin in the glomerulus. In 
many types of glomerulonephritis it is assumed 
that increased accumulation of fibronectin is 
caused by an enhanced production by mesangial 
cells, although earlier reports suggest that it may 
also originate from the plasm a .25 The high stain­
ing intensity with monoclonal antibody against 
all isoforms of fibronectin (IST-4) strongly indi­
cates that a great deal of the fibronectin accumu­
lating in the glomerulus is not produced by glo­
merular cells, but is derived from the plasma. In 
contrast to Mazzucco et ai,^' our finding with 
the monoclonal antibody IST-9 suggests that a 
moderate amount of fibronectin also could be 
derived from resident, probably mesangial cells. 
At this moment it can only be speculated that we 
are dealing with a genetically different form of
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circulating fibronectin that is entrapped in the 
mesangial and subendothelial areas by a mecha­
nism not based on immunologic factors.
The deposits found in this glomerulonephritis 
are arranged in a fine granular fashion or into 
fibrils or microtubules with a diameter o f 10 to
12 nm. Microfibrils with a diameter o f  10 to 12 
nm have been found in the mesangium of normal 
human and rat glom eruli3839; in various forms 
o f  renal disease, such as light chain deposition 
disease and diabetes mellitus40'44; in cultured fi­
broblasts'15; in rat and human aorta46; and in the 
connective tissue of m ice .47“49 There is immuno- 
histological evidence that fibronectin is an im­
portant component in many of the described fi­
brils ,38,41,45,46,40 Inoue et al proposed a model for 
the formation of the microfibrils in the connec­
tive tissue of the mouse, which are at least com­
posed of amyloid P, fibrillin, and fibronectin.47'49 
Using ultrastructural inimunohistology these in­
vestigators found that the microfibrils are built 
up by a microfibrillar tubule consisting mainly 
o f  amyloid P. Fibronectin was found at the sur­
face of this tubule, wrapped around it as a helical 
band .47,49 The presence o f  microtubular structures 
in the deposits of patient no. 2 and our immuno- 
histologic findings o f  the presence o f  amyloid P 
in addition to fibronectin support such a molecu­
lar structure. However, our data are not sufficient 
to propose a general and definite model of this 
kind o f  microfibrils. The finding o f  moderate 
amounts o f  vitronectin* an abundant blood 
plasma protein with many biologic functions, 
such as cell adhesion, complement inhibition, 
and anti-heparin activity, cannot be explained 
sufficiently in terms o f  the molecular structure. 
The presence o f  vitronectin has been reported 
in the normal kidney and in several forms of 
glomerulonephritis .29,30 Vitronectin has been spe­
cifically found in several types of connective tis­
sues attached to the m em brane attack complex 
of the late com plem ent factors .20 We found 
hardly any deposits o f  complement in the glo­
merular accumulations, excluding complement- 
mediated trapping of vitronectin.
W e have described two patients with a rare 
form of fibrillary glomerulonephritis character­
ized by the glomerular accumulation of plasma- 
derived fibronectin together with moderate 
amounts of amyloid P and vitronectin. The num ­
ber of such patients identified to date is too small 
to make definite statements about the pathoge­
netic mechanism that underlines this glomerulo­
nephritis. Clinically, in our patients the disease 
follows a rather indolent course with longstand­
ing proteinuria, but there is no tendency toward 
renal insufficiency,
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